| VLAD
MIKIJANIC
Vice President, Quality Assurance and Regulatory
Affairs
Vlad Mikijanic is the Vice President
of Quality Assurance and Regulatory Affairs for Pharmaceutics
International Inc. (PII), a company that focuses on the development
of formulations and delivery systems for solid, liquid, and
semi-solid dosage pharmaceutical products.
Joining
PII in 2000, Vlad is well versed in all manner of solid dose
manufacturing, and brings with him over twenty-six years of
experience in commercial cGMP and CSA compliance programs,
and Quality Systems implementation. He has represented manufacturing
firms with the National Association of Pharmaceutical Manufacturers
(NAPM) and has served as a member of its Technical Advisory
Committee.
After earning
his BA from Queens College CUNY in 1972, Vlad went on to join
Zenith Laboratories in New Jersey, now part of the IVAX group.
Here he gained extensive experience in Manufacturing, Packaging,
and Production Planning and Inventory Control. When he left
he held the position of Corporate Director of Quality Management
with QA/QC/DEA oversight responsibility for operations at
their New Jersey, Puerto Rico and St. Croix facilities.
In 1991
he left Zenith Labs to join Lannett Pharmaceuticals Inc.,
a generic solid dose manufacturer located in Philadelphia,
PA to serve as Vice President of Technical Affairs. Responsible
for all Quality Assurance, Quality Control, Regulatory Affairs,
and Information Technology functions, he was successful in
restoring the firm's FDA and DEA regulatory profiles by implementing
their strategic Quality Restoration Plan.
Pharmaceutics
International, Inc.
10819 Gilroy Road, Hunt Valley, MD 21031
Phone: 410 584-0001 Fax: 410 584-0007
www.pharm-int.com
Mission Statement: To deliver a quality dosage form development
service which meets all of our customers’ needs in a
timely fashion
|